N-803 (nogapendekin alfa inbakicept [NAI]) , sotevtamab, zabadinostat, gemcitabine, nab-paclitaxel clinical trials

An early safety study testing a drug combination given before possible surgery for people with pancreatic cancer that can’t be easily removed yet or hasn’t spread far

This study looks at new drug combinations for pancreatic cancer that hasn't spread but is hard to remove. It combines standard chemotherapy with three new medicines to see if they can shrink the cancer before surgery and if they are safe.